These studies suggest that STC2 is a positive regulator of tumor progression, and the high expression of STC2 may improve the proliferation and metastasis of tumor cells, thereby altering the clinicopathological characteristics of tumor patients. This evidence concerns the gene STC2 and neoplasm.